This study aimed to epidemiologically investigate factors, including single‐nucleotide polymorphisms (SNPs) associated with alanine aminotransferase (ALT) levels >30 U/L and potential risk factors for liver fibrosis, in a general population cohort of patients with MASLD. This evidence concerns the gene GPT and Hepatic fibrosis.